KELSEY MCKEE: Open Payments
NPI 1295458867 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,386 in 95 payments from 13 companies in 2025. Trend: 2023 $1,540 · 2024 $2,560 · 2025 $2,386
Food & beverage: $2,386
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $556 |
| Janssen Biotech, Inc. | 12 | $379 |
| Aimmune Therapeutics, Inc. | 13 | $304 |
| PFIZER INC. | 15 | $219 |
| Madrigal Pharmaceuticals | 3 | $211 |
| Gilead Sciences, Inc. | 3 | $159 |
| Ardelyx, Inc. | 5 | $120 |
| Phathom Pharmaceuticals, Inc. | 4 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $92 |
| Lilly USA, LLC | 3 | $72 |
Products named: TREMFYA, ZENPEP, RINVOQ, REZDIFFRA, Livdelzi, IBSRELA, XELJANZ, CREON.
Industry payments across FL — which companies pay providers there.
